Emil T. Kuriakose
Corporate Officer/Principal at TERNS PHARMACEUTICALS, INC.
Net worth: 385 484 $ as of 2024-03-30
Profile
Emil T.
Kuriakose is currently the Chief Medical Officer-Oncology at Terns Pharmaceuticals, Inc. He previously worked as a Medical Director at Novartis Oncology, Inc. from 2013 to 2016 and as Vice President & Head-Clinical Development at Calithera Biosciences, Inc. from 2017 to 2021.
He received his undergraduate degree from New York University and his doctorate from Stony Brook University School of Medicine.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2024-03-09 | 58,750 ( 0.09% ) | 385 400 $ | 2024-03-30 | |
2023-04-29 | 3,354 ( 0.07% ) | 84 $ | 2024-03-30 |
Emil T. Kuriakose active positions
Companies | Position | Start |
---|---|---|
TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2023-04-30 |
Former positions of Emil T. Kuriakose
Companies | Position | End |
---|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Chief Tech/Sci/R&D Officer | 2015-12-31 |
CALITHERA BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Training of Emil T. Kuriakose
New York University | Undergraduate Degree |
Stony Brook University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
CALITHERA BIOSCIENCES, INC. | Health Technology |
TERNS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 1 |
---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- Emil T. Kuriakose